ARCC vs. TMO
ARCC (Ares Capital Corporation) and TMO (Thermo Fisher Scientific Inc.) are both stocks. ARCC operates in Asset Management (Financial Services), while TMO operates in Diagnostics & Research (Healthcare). Over the past 10 years, ARCC returned 12.48%/yr vs 13.19%/yr for TMO. At a 0.35 correlation, their price movements are largely independent.
Performance
ARCC vs. TMO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARCC achieves a -1.16% return, which is significantly higher than TMO's -9.00% return. Over the past 10 years, ARCC has underperformed TMO with an annualized return of 12.48%, while TMO has yielded a comparatively higher 13.19% annualized return.
ARCC
- 1D
- -0.99%
- 1M
- 5.27%
- 6M
- -4.32%
- YTD
- -1.16%
- 1Y
- -9.88%
- 3Y*
- 8.83%
- 5Y*
- 8.74%
- 10Y*
- 12.48%
- ALL TIME*
- 12.05%
TMO
- 1D
- -1.17%
- 1M
- 13.26%
- 6M
- -14.78%
- YTD
- -9.00%
- 1Y
- 27.34%
- 3Y*
- -1.87%
- 5Y*
- 0.74%
- 10Y*
- 13.19%
- ALL TIME*
- 12.05%
ARCC vs. TMO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ARCC Ares Capital Corporation | -1.16% | 1.07% | 19.78% | 20.03% | -3.84% | 36.14% | 0.86% | 31.30% | 8.81% | 4.50% |
TMO Thermo Fisher Scientific Inc. | -9.00% | 11.78% | -1.72% | -3.36% | -17.29% | 43.54% | 43.72% | 45.55% | 18.21% | 35.03% |
Correlation
The correlation between ARCC and TMO is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.29 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.33 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Oct 6, 2004 | 0.35 |
Fundamentals
ARCC:
$13.63B
TMO:
$195.56B
ARCC:
$1.62
TMO:
$18.24
ARCC:
11.70
TMO:
28.85
ARCC:
5.11
TMO:
4.38
ARCC:
0.97
TMO:
3.78
ARCC:
$2.63B
TMO:
$45.20B
ARCC:
$1.86B
TMO:
$17.81B
ARCC:
$2.05B
TMO:
$11.16B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARCC vs. TMO — Risk / Return Rank
ARCC
TMO
ARCC vs. TMO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ares Capital Corporation (ARCC) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARCC | TMO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.40 | ||
| Sortino ratioReturn per unit of downside risk | -2.12 | ||
| Omega ratioGain probability vs. loss probability | 0.93 | 1.18 | -0.25 |
| Calmar ratioReturn relative to maximum drawdown | -0.53 | 0.88 | -1.40 |
| Martin ratioReturn relative to average drawdown | -0.91 | 1.74 | -2.65 |
Loading charts...
Drawdowns
ARCC vs. TMO - Drawdown Comparison
The maximum ARCC drawdown since its inception was -79.36%, which is greater than TMO's maximum drawdown of -71.16%. Use the drawdown chart below to compare losses from any high point for ARCC and TMO.
Loading charts...
Drawdown Indicators
| ARCC | TMO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -79.36% | -71.16% | -8.20% |
Max Drawdown (1Y)Largest decline over 1 year | -18.86% | -31.38% | +12.52% |
Max Drawdown (3Y)Largest decline over 3 years | -19.35% | -37.28% | +17.93% |
Max Drawdown (5Y)Largest decline over 5 years | -21.76% | -40.95% | +19.19% |
Max Drawdown (10Y)Largest decline over 10 years | -56.77% | -40.95% | -15.82% |
Current DrawdownCurrent decline from peak | -10.03% | -20.09% | +10.06% |
Average DrawdownAverage peak-to-trough decline | -9.12% | -18.12% | +9.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.21% | 15.79% | -4.58% |
Volatility
ARCC vs. TMO - Volatility Comparison
The current volatility for Ares Capital Corporation (ARCC) is 4.12%, while Thermo Fisher Scientific Inc. (TMO) has a volatility of 7.76%. This indicates that ARCC experiences smaller price fluctuations and is considered to be less risky than TMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARCC | TMO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.12% | 7.76% | -3.64% |
Volatility (6M)Calculated over the trailing 6-month period | 14.85% | 22.95% | -8.10% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.90% | 31.33% | -12.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.99% | 27.37% | -7.38% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.58% | 26.42% | -0.84% |
Dividends
ARCC vs. TMO - Dividend Comparison
ARCC's dividend yield for the trailing twelve months is around 10.12%, more than TMO's 0.34% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARCC Ares Capital Corporation | 10.12% | 9.49% | 8.77% | 9.59% | 10.12% | 7.65% | 9.47% | 9.01% | 9.88% | 9.67% | 9.22% | 11.02% |
TMO Thermo Fisher Scientific Inc. | 0.34% | 0.30% | 0.30% | 0.26% | 0.22% | 0.16% | 0.19% | 0.23% | 0.30% | 0.32% | 0.43% | 0.42% |
Financials
ARCC vs. TMO - Financials Comparison
This section allows you to compare key financial metrics between Ares Capital Corporation and Thermo Fisher Scientific Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ARCC vs. TMO - Profitability Comparison
ARCC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Ares Capital Corporation reported a gross profit of 550.00M and revenue of 763.00M. Therefore, the gross margin over that period was 72.1%.
TMO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Thermo Fisher Scientific Inc. reported a gross profit of 4.48B and revenue of 11.01B. Therefore, the gross margin over that period was 40.7%.
ARCC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Ares Capital Corporation reported an operating income of 404.00M and revenue of 763.00M, resulting in an operating margin of 53.0%.
TMO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Thermo Fisher Scientific Inc. reported an operating income of 1.86B and revenue of 11.01B, resulting in an operating margin of 16.9%.
ARCC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Ares Capital Corporation reported a net income of 92.00M and revenue of 763.00M, resulting in a net margin of 12.1%.
TMO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Thermo Fisher Scientific Inc. reported a net income of 1.65B and revenue of 11.01B, resulting in a net margin of 15.0%.
Frequently Asked Questions
ARCC and TMO have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TMO has higher volatility (7.76%) compared to ARCC (4.12%). In terms of maximum drawdown, ARCC dropped -79.36% vs TMO's -71.16%.
TMO currently has the higher Sharpe Ratio (0.88 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARCC and TMO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer